Following the Supreme Court's 2022 Dobbs ruling that overturned Roe v. Wade, voters in 17 states have voted on abortion-related ballot initiatives. The pro-choice side won in 14 of those states, including Kansas, Kentucky and Ohio. In the 2024 midterm cycle, voters in Missouri, Nevada and Virginia also approved measures protecting abortion rights, while Idaho rejected a similar proposal.
State Ballot Measures and Their Outcomes
Stateballot measures have become a key battleground for abortion policy. In Kansas, a measure to protect abortion rights passed with 52 percent of the vote. Kentucky's ballot measure also received majority support, and Ohio's voters approved a similar initiative. Missouri, Nevada and Virginia all saw their rights-protecting measures approved by voters, whereas Idaho's measure was rejected by a narrow margin.
Democratic Control of State Legislatures and Executive Branches
In 2024, Democratic candidates who support abortion rights secured trifectas, control of the governor's office, both legislative chambers, in six pivotal states. These states include Michigan, Minnesota, Nevada, Pennsylvania, Wisconsin and Arizona. This shift marks the first time in more than 15 years that Democrats have held majority control of a state legislature in each of these states.
Democrats now govern 28, possibly 29, states. They have also flipped five state attorneys general offices, including the Texas office, which had been a long-standing Republican stronghold. The combined effect of these gains is a solid Democratic majority in the U.S. Congress, which is expected to support legal abortion more robustly than previous Congresses.
Why the Word "Abortion" Is Still Avoided on Campaign Trails
Despite the clear electoral support for abortion rights, many Democratic candidates have steered clear of the word "abortion" during their campaigns. Some view it as a polarizing issue that could hurt their chances in swing districts. However, voters have repeatedly shown that they care about reproductive freedom, as evidenced by their votes on ballot initiatives and for Democratic candidates who champion the issue.
The Legal Landscape for Mifepristone and Telemedicine Abortion
Since the Dobbs decision, the debate over abortion has largely focused on mifepristone, a medication used safely for more than 25 years for abortion and miscarriage management. In 2023, medication abortion, typically starting with mifepristone, accounted for 64 percent of clinician-provided abortions, according to the Guttmacher Institute. By 2025, telehealth abortion, which relies heavily on mifepristone, represented 27 percent of U.S. abortions, per the Society of Family Planning.
Hundreds of thousands of women each year depend on mifepristone. Laws that protect access to the pill are essential, especially as anti-abortion forces intensify their attacks on its availability. Telemedicine abortion shield laws enacted in eight states after Dobbs protect clinicians and supporters who provide care across state lines. These laws allow patients to receive medication abortion even when travel would be too expensive or impractical due to work, school or childcare commitments.
Success of Telemedicine Shield Laws
Telemedicine shield laws have withstood legal challenges. In January, Louisiana sought to extradite a California doctor providing telehealth abortion services. Governor Gavin Newsom (D) invoked California's shield law and refused the extradition request. In another case, Texas obtained a default judgment exceeding $100,000 against a New York doctor. A court clerk refused to enter the judgment, and a judge upheld that refusal, citing New York's shield law.
Abortion opponents recognize the power of telemedicine. Last May, a federal appeals court reinstated a nationwide requirement that mifepristone be dispensed only to patients appearing in person. A Supreme Court stay has maintained mail delivery of the pill while the case proceeds.
FDA Actions and Political Interference
Under Health Secretary Robert F. Kennedy Jr., the FDA ordered an unnecessary safety review of mifepristone, scheduled for release in March 2027, despite the drug's 25-year global safety record. Dr. Heidi Overton, the president's nominee to run the FDA, was criticized during her confirmation hearing for her remarks about the agency's decision to allow mail delivery, calling it "chemical abortion on demand."
Supreme Court and State Attorney General Litigation
In September, attorneys general from Louisiana, Alabama and Arkansas asked the Supreme Court to hear their lawsuit against New York, California and Massachusetts, seeking to invalidate the shield laws of those states. The same attorneys general also filed a separate federal suit against 30 alleged telemedicine providers and supporters. If either case succeeds, abortion access could decline nationwide. These officials are allocating significant state resources to override other states' laws, rather than focusing solely on their own bans.
Political Strategies to Protect Abortion Rights
Democrats must act decisively. Senators can reject Dr. Overton's nomination and demand that the FDA provide evidence before proceeding with the safety review. When President Trump seeks Senate confirmation for his administration or Supreme Court justices in the next two years, Democrats should support candidates who uphold abortion rights.
Attorneys general can defend shield laws in court and join the mifepristone cases on the side of patients. Governors and legislators can protect clinicians who prescribe mifepristone, even if the FDA interferes with the science of its safety. New York has a law supporting mifepristone access that has passed both chambers and awaits Governor Kathy Hochul's (D) signature.
New Jersey, Connecticut and Maryland had shield legislation pending in the last session. States that have recently become Democratic trifectas, Michigan, Minnesota, Nevada, Pennsylvania, Wisconsin and Arizona, likely have the votes to enact similar protections. California can reinforce its commitment to refuse extradition of abortion providers by passing a bill that Governor Newsom vetoed last September; Governor-elect Xavier Becerra (D) has the opportunity to sign it when it reaches his desk next session.
What Voters and Politicians Have Done So Far
Voters in 17 states have already demonstrated their support for abortion rights through ballot initiatives. Democratic candidates have won significant legislative and executive positions, giving them the authority to enact protective laws. However, the legal landscape remains volatile, with federal and state courts continuing to test the limits of abortion access.
Background: The Dobbs Decision and Its Aftermath
The Supreme Court's 2022 decision in Dobbs v. Jackson Women's Health Organization overturned Roe v. Wade, removing the federal constitutional guarantee of abortion rights. States immediately moved to enact bans or restrictions, leading to a patchwork of laws across the country. Some states, like New Mexico and Colorado, reinforced protections, while others, such as Alabama and Mississippi, imposed near-total bans.
The political fallout was swift. Democrats gained momentum in the 2022 midterms, flipping several state legislatures and gaining control of the U.S. Senate. The 2024 election cycle has continued that trend, with Democrats securing more governorships and legislative majorities.
What Happens Next for Abortion Policy
The next steps involve several key actions. The FDA's pending safety review of mifepristone will be closely monitored by reproductive rights advocates. State legislatures with Democratic majorities are expected to pass shield laws and mifepristone-supporting statutes. Federal courts will determine the outcome of the lawsuits filed by conservative states against shield laws. The Supreme Court may also hear related cases, which could set nationwide precedents.
Meanwhile, voters will continue to shape policy through ballot measures in future elections. The political landscape will remain dynamic as parties and activists respond to legal and legislative developments.
Julie F. Kay, a human rights attorney, is the founder and CEO of Reproductive Futures and co-author of "Controlling Women: What We Must Do Now to Save Reproductive Freedom."